References
- Murphy C, Thomas FP. Open science gathers momentum: implications for medical and scientific research. J Spinal Cord Med 2023;46(6):873–874.
- Center for Biomedical Research Transparency. Null Hypothesis Initiative. Available from: www.cbmrt.org
- PLOS. Filling in the scientific record: the importance of negative and null results. PLOS EveryONE Blog. April 6, 2020. Available from: https://everyone.plos.org/2020/04/06/filling-in-the-scientific-record-the-importance-of-negative-and-null-results/
- Munafo M, Neill J. Null is beautiful: on the importance of publishing null results. J Psychopharmacol 2016;30(7):585, doi:10.1177/0269881116638813
- Editorial (No authors listed). In praise of replication studies and null results. Nature 2020;578:489, doi:10.1038/d41586-020-00530-6
- Ornes S. Null results, replication studies and other important science find a home. 21 July 2021. American Society of Microbiology. Available from: https://asm.org/Articles/2021/July/Null-Results,-Replication-Studies-and-Other-Import
- Baker M. 1,500 scientists lift the lid on reproducibility. Nature 2016;533:452–454. doi:10.1038/533452a.
- Petty S, Stephenson H, Hadley S. Shining more light on dark data. Science Editor 2020;43(1):7–10, Dec 2019. Available from: https://www.csescienceeditor.org/article/shining-more-light-on-dark-data
- Warren M. First analysis of ‘pre-registered’ studies shows sharp rise in null findings. 24 Oct 2018. Available from: Nature.com, https://www.nature.com/articles/d41586-020-00530-6
- Berlin Institute of Health @ Charité. The QUEST 1,000 € NULL Results Award. Available from: https://www.bihealth.org/en/translation/innovation-enabler/quest-center/calls-and-awards/quest-calls-and-awards/null-and-replication/
- Murudkar S. Top 10 journals to publish your negative results. Engago Academy. 30 Sept 2021. [cited 2023 Dec 1]. Available from: https://www.enago.com/academy/top-10-journals-publish-negative-results/
- Echevarria L, Alerba A, Arechavala-Gomeza V. Researcher’s perceptions on publishing “negative” results and open access. Nucleic Acid Ther 2021 Jun;31(3):185–189. doi:10.1089/nat.2020.0865
- Thomas FP, Brannagan TH, Butterfield RJ, Desai U, Habib AA, et al. Randomized phase 2 study of ACE-083 in patients with Charcot–Marie–Tooth disease. Neurology 2022 Jun;98(23):e2356–e2367. doi:10.1212/WNL.0000000000200325